Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

about

Pseudophakic bullous keratopathy.Prox1-GFP/Flt1-DsRed transgenic mice: an animal model for simultaneous live imaging of angiogenesis and lymphangiogenesis.

P2860

Q47160690-3B7E14D9-BE1A-4F62-A55C-036A5D5CAF0C Q50506414-5B698D64-56B2-483F-A378-93237291EF17

P2860

Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

Item

http://www.wikidata.org/entity/Q38904800

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

@en

type

Item

label

Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

@en

prefLabel

Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

@en

P1476

Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

@en

P2093

Ahmad Kheirkhah

http://www.w3.org/2001/XMLSchema#string

Antonio Di Zazzo

http://www.w3.org/2001/XMLSchema#string

Reza Dana

http://www.w3.org/2001/XMLSchema#string

Tulio B Abud

http://www.w3.org/2001/XMLSchema#string

P2860

Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function

Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity

Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study

The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo

Prospects for gene therapy in corneal disease.

Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells

Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival

P304

81-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2008-322X.200156

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28299010

http://www.w3.org/2001/XMLSchema#string

P932

5340067

http://www.w3.org/2001/XMLSchema#string

Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

about

P2860

P2860

Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932